The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


GRANOCYTE 13 million IU/mL, powder and solvent for solution for injection/infusion, in a pre-filled syringe



Chugai Pharma FrancePA22641/002/002

Main Information

Trade NameGRANOCYTE 13 million IU/mL, powder and solvent for solution for injection/infusion, in a pre-filled syringe
Active SubstancesLenograstim
Dosage FormPowder and solvent for solution for injection/infusion
Licence HolderChugai Pharma France
Licence NumberPA22641/002/002

Group Information

ATC CodeL03AA Colony stimulating factors
L03AA10 lenograstim

Status

License statusAuthorised
Licence Issued01/09/2009
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back